* Pfizer Pharma GmbH and apoplex medical technologies GmbH have signed today an agreement on a German wide cooperation in field of stroke prevention
May 13 (Reuters) - An experimental Pfizer Inc drug that aims to help lung cancer patients with specific genetic mutations who have stopped responding to the company's Xalkori was showing promise in a small, early stage study, according to preliminary data revealed on Wednesday.
* DKSH Business Unit Healthcare has signed agreement to provide marketing, sales, logistics, distribution, credit management and -collection services to Pfizer in Laos
CLX 3.56 Walmart WMT 3.37 Sysco SYY 3.28 3M MMM 3.20 Suburban Propane SPH 3.16 Johnson & Johnson JNJ 3.06 Pfizer PFE 2.93 Spectra Energy SE 2.89 Coca-Cola KO 2.87 Merk MRK 2.85 General Mills GIS 2.85 Linear Technology LLTC
NEW YORK/LONDON (Reuters) - Pfizer Inc is the mystery bidder for Swedish Orphan Biovitrum AB , the rare disease specialist which disclosed this week that a potential buyer had made a preliminary offer, people with knowledge of the situation said.
potential catalyst for the company, we believe it will face a challenging environment given the disappointing launch of Pfizer 's Xeljanz. In addition, its broad Phase II program for its IDO1 inhibitor INCB24360 continues to advance in combination
pipeline. Several of Bayer’s cancer drugs (ODM-201, BAY 86-9766, copanlisib) will enter crowded markets. Also, cardiometabolic drug finerenone holds a similar mechanism of action as Pfizer ’s failed eplerenone.
appears to be concerns that the firm's largest customer ( Pfizer ) has added a third preferred contract research organization ..... monitor any changing dynamics in the firm's bookings with Pfizer . Management updated its 2015 guidance to $3.60-3
the first quarter is because nearly 4% of the index is in Apple ( AAPL ), which advanced by about 13%. Drugmaker Pfizer ( PFE ) is the index’s tenth holding and also had positive performance in the quarter. Over the past 12 months, Apple
April 28 (Reuters) - U.S. drugmaker Pfizer Inc cut its full-year revenue and profit forecast, blaming a stronger dollar.